The AI In Respiratory Diseases market was valued at USD 9.10 Billion in 2024 and is expected to reach USD 83.37 Billion by 2032, growing at a CAGR of 31.9% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.